Why is AST SpaceMobile stock rising today? Meta Platforms partnership speculation, resistance levels in focus

Traders Union
All News
Stocks
AST SpaceMobile jumps 1.76% to $61.06

Highlights

AST SpaceMobile delayed the commercial launch of its 45-satellite network to 2027 after a ground test anomaly in June 2026, extending its path to revenue.
Investor attention increased on liquidity and execution risks with $3.7 billion in reserves as the company faces multiple securities class action lawsuits over capital sufficiency claims.
Shares of AST SpaceMobile trade below key moving averages with weak daily momentum, and price is expected to range between $57.74 and $64.38, with lower probability of an upward move.

Liquidity and legal fears intensify after satellite delay and lawsuits

AST SpaceMobile has postponed the commercial launch of its 45-satellite network to 2027 following a ground test anomaly in late June 2026, an event that extends its path to revenue and raises questions over whether its $3.7 billion cash reserves will bridge the added delay, according to PR Newswire. This development has amplified investor focus on liquidity and execution risks and has coincided with multiple securities class action lawsuits from Pomerantz LLP, SueWallSt, and Rosen Law Firm, targeting alleged misleading statements about capital sufficiency and dilution across 2025 and 2026. Separately, renewed speculation about a potential partnership with Meta Platforms, as noted by Benzinga, continues to inject volatility and headline-driven trading interest into the stock.

Mixed momentum signals as support levels offset intermittent buyer activity

On the daily chart, ASTS is currently positioned below its MA-20, above the MA-50, and well below the MA-200, highlighting several key technical tension points. The Ichimoku Kijun sits at $61.88 and marks immediate resistance. Among momentum indicators, MACD shows selling pressure, while ADX remains neutral. RSI is just below mid-range and signals a sell bias; both Stochastic RSI and CCI are neutral, indicating neither overbought nor oversold conditions. Bull/Bear Power reflects intraday buyer dominance despite weak daily momentum readings, and the Awesome Oscillator is neutral, providing no directional confirmation. This overlap of neutral and negative momentum with intermittent buyer strength sets a mixed short-term technical context.

Range-bound trading likely amid resistance and low breakout odds

Over the next 2–3 trading days, ASTS is expected to fluctuate within a $57.74 to $64.38 volatility band relative to current levels. The probability of an upward move is estimated at 24%, suggesting the most likely scenario is range-bound price action between recent highs and lows. Should the stock clear the Ichimoku Kijun resistance at $61.88, there is scope for a move to the upper end of the range, while a breakdown below support could drive losses toward the range low.

Anton Kharitonov, expert at Traders Union, views the latest events around AST SpaceMobile as heightening both operational and legal risks while uncertainty lingers over the company’s commercial timeline. He notes that technical signals are mixed at best, with sellers maintaining short-term pressure and key resistance yet to be cleared. The analyst points to renewed volatility from speculation and litigation, but doubts any sustainable upside without a break of $61.88. "Base case remains range-bound — until the stock pushes past the Kijun, caution is warranted."

Earlier, analysts noted that AST SpaceMobile faced persistent downside risks stemming from launch delays, legal challenges, and uncertainty around its long-term outlook. The current setup reinforces those concerns with ongoing legal exposure and a delayed revenue timeline, meaning traders should focus on price reactions around the $61.88 Ichimoku Kijun resistance as a near-term gauge of directional momentum.

Source of Data: ASTS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.